NUS
Nu Skin Enterprises, Inc.
NUS lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve.
NUS Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Under pressure | |
| Stable |
NUS's balance sheet is currently stable, but its revenue, profitability and cash flow are under pressure.
NUS PE Valuation
NUS has no meaningful PE right now: it lost money over the past year.
NUS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect NUS's earnings to grow and its profitability to improve, with its revenue holding steady.
NUS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.08 | — |
| Q3 2026 | -$4.85 | -322% |
| Q2 2026 | -$4.49 | -323% |
| Q1 2026 | $1.08 | +$1.88 |
| Q4 2025 | $3.18 | +$6.13 |
| Q3 2025 | $2.18 | +$4.26 |
| Q2 2025 | $2.01 | +$5.00 |
| Q1 2025 | -$0.80 | -$0.73 |
| Q4 2024 | -$2.95 | -1835% |
NUS has swung to a loss: it lost $4.85 per share over the past year, after a profit the year before.
NUS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $311M | -15% |
| Q2 2026 | $320.1M | -17% |
| Q1 2026 | $320.6M | -12% |
| Q4 2025 | $370.3M | -17% |
| Q3 2025 | $364.2M | -15% |
| Q2 2025 | $386.1M | -12% |
| Q1 2025 | $364.5M | -13% |
| Q4 2024 | $445.6M | -8.8% |
NUS's revenue has slid since its 2020 peak: $311M last quarter, down 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.6% | -4.3 points |
| Q2 2026 | -19% | -27 points |
| Q1 2026 | 1.3% | +4 points |
| Q4 2025 | 6.3% | +18 points |
| Q3 2025 | 5.9% | +1.7 points |
| Q2 2025 | 8% | +37 points |
| Q1 2025 | -2.7% | -4.8 points |
| Q4 2024 | -12% | -15 points |
NUS's operating margin was 1.6% last quarter, down 4.3 points from the same quarter a year ago.
NUS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$19.5M | -211% |
| Q2 2026 | $5M | -86% |
| Q1 2026 | -$17.6M | -$4.4M |
| Q4 2025 | $5.9M | -56% |
| Q3 2025 | $17.6M | -23% |
| Q2 2025 | $35.8M | -17% |
| Q1 2025 | -$13.2M | -$4.2M |
| Q4 2024 | $13.2M | -61% |
NUS's free cash flow has turned negative after years in the green: −$26M over the past year.
NUS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +81K shares |
| 1 year | -3.2% | -1.6M shares |
| 3 years | -2.4% | -1.2M shares |
| 5 years | -5% | -2.6M shares |
| Available history | -13% | -7.3M shares |
NUS has 49M diluted shares, down 3.2% from a year ago, with $15M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $5M |
| Q4 2025 | $10M |
| Q3 2025 | $5M |
| Q2 2025 | — |
| Q1 2025 | $5M |
| Q4 2024 | — |
NUS spent $15M buying back its own shares over the past year, up 50% from the year before.
NUS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.2x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.5x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2024 | 2.4x | Moderate |
| Q4 2023 | 2.1x | Moderate |
NUS's net debt is about 1.6 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
NUS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.1 | Neutral |
| Stochastic | 9.6 | Oversold |
NUS's weekly RSI is 30 (neutral) and its Stochastic is 10 (oversold).
NUS PE vs Consumer Defensive Sector
| Metric | NUS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | — |
NUS has no meaningful PE right now: it lost money over the past year.
NUS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.58 | 12% below |
| 20 week MA | $4.83 | 17% below |
| 50 week MA | $6.79 | 41% below |
| 100 week MA | $7.68 | 48% below |
| 200 week MA | $14.2 | 72% below |
NUS is in a downtrend: it's below all five of its weekly moving averages, and 72% below its 200-week average.
NUS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $40.5 | $54.6 | +35% |
| 2021 | $54.6 | $49.5 | -9.3% |
| 2022 | $49.5 | $41.6 | -16% |
| 2023 | $41.6 | $19.4 | -53% |
| 2024 | $19.4 | $6.76 | -65% |
| 2025 | $6.76 | $9.84 | +46% |
| 2026 YTD | $9.84 | $4.01 | -59% |
NUS has finished lower in four of the last six years. It's down 59% so far in 2026.